Q32 Bio Inc. (QTTB)
Last updated: 2026-10-21 05:44:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Q32 Bio Inc. (QTTB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $8.63, with a market capitalization of $223.87M and a P/E ratio of 6.86. Over the past 52 weeks, its price has ranged from $1.91 to $23.57. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$223.87M | |
$7.79 | |
$53.79 | |
$1.35 | |
$7.79 | |
463.82K | |
724.57K | |
6.86 | |
$23.57 | |
$1.91 | |
-- | |
-- |
Q32 Bio Inc. (QTTB) Latest Closing Stock Price
Q32 Bio Inc. (QTTB) last closed at $7.79 as of 2026-10-20 23:31:00, unchanged from the previous close of $7.79.
During the latest regular trading session, QTTB traded between $1.35 and $53.79, with a volume of 463.82K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Q32 Bio Inc. (QTTB) 7-Day Stock Price Change
Over the past seven days, Q32 Bio Inc. (QTTB) moved from $8.34 to $8.63, representing a gain of 3.47% ($0.29).
The stock traded between $7.28 and $9.16 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 723.33 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
QTTB 52-Week Price Position
Position in Range: 31.0%
QTTB is currently trading at $8.63, placing it 31.0% of the way from its 52-week low of $1.91 to its 52-week high of $23.57. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Q32 Bio Inc. (QTTB)?
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
Q32 Bio Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 22 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Q32 Bio Inc. (QTTB) Stock on MEXC
Eligible investors can buy real shares of Q32 Bio Inc. (QTTB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Q32 Bio Inc. (QTTB) stock price today?
2.Is QTTB stock going up or down today?
3.What is QTTB pre-market price?
4.What is QTTB after-hours price?
5.Is QTTB stock trading now?
6.Where does QTTB sit relative to its 52-week high and low?
7.What sector is Q32 Bio Inc. in?
8.What is Q32 Bio Inc.'s market capitalization and where is it listed?
9.How is QTTB valued in terms of P/E ratio and EPS?
10.Does Q32 Bio Inc. pay a dividend?
Explore More US Stocks
Search Stocks
QTTB Stock Calculator
Estimate the value between QTTB shares and USD.
QTTB Shares to USD
1.00 QTTB shares = 8.629 USD
Calculations are estimates based on the latest available price and are for reference only.


